← Back to Screener
Quest Diagnostics Inc. (DGX)
Price$192.20
Value ScoreC
Growth ScoreD
Momentum ScoreC
Favorite Metrics
Price vs S&P 500 (26W)-12.04%
Price vs S&P 500 (4W)-3.81%
VGM Score44.68
Market Capitalization$21.57B
P/E Ratio (Annual)21.75x
Indicated Dividend Yield (Annual)1.77%
All Metrics
P/CF (Annual)11.44x
Book Value / Share (Quarterly)$66.36
P/TBV (Annual)3.49x
Indicated Dividend (Annual)$3.44
Revenue Growth (3Y)3.74%
Cash Flow / Share (Quarterly)$11.95
Payout Ratio (TTM)34.86%
Price vs S&P 500 (YTD)1.38%
Gross Margin (TTM)33.27%
Net Profit Margin (TTM)9.08%
EPS (TTM)$9.08
10-Day Avg Trading Volume0.85M
EPS Excl Extra (TTM)$9.08
Revenue Growth (5Y)3.18%
EPS (Annual)$8.78
Dividend / Share (Annual)$3.19
ROI (Annual)7.61%
Gross Margin (Annual)33.32%
Net Profit Margin (5Y Avg)11.02%
Cash / Share (Quarterly)$3.54
P/E Basic Excl Extra (TTM)21.07x
Revenue Growth QoQ (YoY)9.16%
EPS Growth (5Y)-3.56%
P/E Normalized (Annual)21.75x
ROA (Last FY)6.11%
Revenue Growth TTM (YoY)11.03%
EBITD / Share (TTM)$15.62
ROE (5Y Avg)17.45%
Operating Margin (TTM)14.27%
Cash Flow / Share (Annual)$12.35
P/B Ratio2.93x
P/B Ratio (Quarterly)2.95x
Net Income / Employee (Annual)$21,600
EV / Revenue (TTM)2.38x
Net Interest Coverage (TTM)6.38x
ROA (TTM)6.30%
EPS Growth QoQ (YoY)15.57%
EV / EBITDA (TTM)15.24x
EPS Incl Extra (Annual)$8.78
Current Ratio (Annual)1.04x
Quick Ratio (Quarterly)0.91x
3-Month Avg Trading Volume0.96M
52-Week Price Return13.31%
EV / Free Cash Flow (Annual)19.75x
P/E Incl Extra (TTM)21.07x
Revenue / Employee (TTM)$245,200
Tangible BV / Share (Quarterly)$50.89
P/S Ratio (Annual)1.96x
Asset Turnover (Annual)0.68x
52-Week High$213.50
Operating Margin (5Y Avg)15.58%
EPS Excl Extra (Annual)$8.78
CapEx CAGR (5Y)4.74%
Tangible BV CAGR (5Y)-0.21%
26-Week Price Return3.89%
Quick Ratio (Annual)0.80x
13-Week Price Return-7.67%
Total Debt / Equity (Annual)0.82x
Current Ratio (Quarterly)1.18x
Enterprise Value$26.84B
Revenue / Share Growth (5Y)7.07%
Asset Turnover (TTM)0.69x
Book Value / Share Growth (5Y)5.10%
Revenue / Employee (Annual)$239,900
Inventory Turnover (Annual)39.03x
Pretax Margin (Annual)11.94%
Cash / Share (Annual)$3.82
3-Month Return Std Dev20.60%
Gross Margin (5Y Avg)34.87%
Net Income / Employee (TTM)$22,300
EBITDA CAGR (5Y)-3.79%
EBITDA Interim CAGR (5Y)-8.69%
ROE (Last FY)13.84%
Net Interest Coverage (Annual)6.71x
EPS Basic Excl Extra (Annual)$8.78
P/FCF (TTM)16.27x
Receivables Turnover (TTM)7.54x
EV / Free Cash Flow (TTM)20.24x
Total Debt / Equity (Quarterly)0.77x
EPS Incl Extra (TTM)$9.08
Receivables Turnover (Annual)8.14x
ROI (TTM)7.92%
Dividend Growth Rate (5Y)7.42%
P/S Ratio (TTM)1.91x
Pretax Margin (5Y Avg)14.53%
Revenue / Share (Annual)$97.65
Tangible BV / Share (Annual)$50.31
Forward P/E17.54x
Free OCF CAGR (5Y)-3.05%
Price vs S&P 500 (52W)-14.89%
P/E Ratio (TTM)21.07x
EPS Growth TTM (YoY)14.88%
Year-to-Date Return12.31%
5-Day Price Return-0.16%
EPS Normalized (Annual)$8.78
ROA (5Y Avg)7.92%
Net Profit Margin (Annual)8.99%
Month-to-Date Return0.36%
Cash Flow / Share (TTM)$10.91
EBITD / Share (Annual)$15.13
EPS Growth (3Y)3.07%
Operating Margin (Annual)14.10%
LT Debt / Equity (Annual)0.72x
P/CF (TTM)11.66x
ROI (5Y Avg)10.05%
P/E Excl Extra (TTM)21.07x
LT Debt / Equity (Quarterly)0.70x
EPS Basic Excl Extra (TTM)$9.08
P/TBV (Quarterly)3.85x
Payout Ratio (Annual)35.58%
P/B Ratio (Annual)2.69x
Dividend / Share (TTM)$3.20
Inventory Turnover (TTM)36.36x
Pretax Margin (TTM)12.20%
Book Value / Share (Annual)$65.18
Price vs S&P 500 (13W)-17.42%
Net Margin Growth (5Y)-9.92%
Dividend Yield (TTM)1.65%
Beta0.59x
P/FCF (Annual)15.88x
Revenue / Share (TTM)$100.70
ROE (TTM)14.11%
52-Week Low$164.65
vGradeC
gGradeD
mGradeC
vgmGradeC
Show chart for
Earnings Surprise History
Q1 262.50est. 2.37
Analyst Recommendations
Feb 2026
Mar 2026
Apr 2026
May 2026
3.79
3.79
3.79
3.79
Industry Peers — Health Services(28)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
DGXQuest Diagnostics Inc. | C | D | C | $192.20 |
| NTRANatera, Inc. Common Stock | F | A | B | $218.81 |
| LHLabcorp Holdings Inc. | C | D | C | $256.87 |
| EXASExact Sciences Corp | F | B | B | $0.00 |
| GHGuardant Health, Inc. Common Stock | F | A | A | $129.14 |
| CELCCelcuity Inc. Common Stock | — | — | B | $122.96 |
| CAICaris Life Sciences, Inc. Common Stock | F | F | C | $16.45 |
| RDNTRadNet, Inc. Common Stock | D | C | D | $52.89 |
| VCYTVeracyte, Inc. | D | A | B | $48.18 |
| GRALGRAIL, Inc. Common Stock | D | A | B | $64.40 |
| FTREFortrea Holdings Inc. Common Stock | B | F | A | $15.76 |
About
Quest Diagnostics is the leading independent provider of diagnostic testing services in the United States, generating over 97% of revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse screening delivered via a nationwide network of approximately 2,400 patient service centers and partnerships with healthcare providers. The company's diagnostic solutions segment provides supplementary services including clinical trials testing, risk-assessment services, and healthcare information technology solutions.